Shanghai Junshi Biosciences Co., Ltd. (1877.HK)
HKD 12.66
(0.48%)
HKD 12.66
(0.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.5 Billion | 1.45 Billion | 4.02 Billion | 1.59 Billion | 775.08 Million | 934 Thousand |
| Cost of Revenue | 667.29 Million | 526.28 Million | 1.25 Billion | 372.53 Million | 90.68 Million | 267 Thousand |
| Gross Profit | 835.26 Million | 927.21 Million | 2.76 Billion | 1.22 Billion | 684.4 Million | 667 Thousand |
| Operating Expenses | 3.28 Billion | 3.64 Billion | 3.35 Billion | 2.89 Billion | 1.47 Billion | 684.79 Million |
| Selling, General and Administrative Expenses | 1.4 Billion | 1.29 Billion | 1.38 Billion | 1.13 Billion | 564.28 Million | 145.14 Million |
| Research and Development Expenses | 1.93 Billion | 2.38 Billion | 2.06 Billion | 1.77 Billion | 946.1 Million | 538.18 Million |
| Other Expenses | -11 Million | -34.18 Million | -91.89 Million | -18.55 Million | -31.54 Million | 17.02 Million |
| Cost and Expenses | 3.95 Billion | 4.17 Billion | 4.61 Billion | 3.26 Billion | 1.56 Billion | 685.05 Million |
| Operating Income | -2.45 Billion | -2.67 Billion | -685.33 Million | -1.67 Billion | -764.44 Million | -679.48 Million |
| Interest Expense | 29 Million | 29.37 Million | 21.83 Million | 29.39 Million | 13.3 Million | 2.08 Million |
| Income Tax Expense | 43.99 Million | -93.1 Million | 135.53 Million | -3.82 Million | -18.89 Million | -1.21 Million |
| Earnings before Tax | -2.48 Billion | -2.67 Billion | -592.64 Million | -1.66 Billion | -763.12 Million | -717.71 Million |
| Net Income | -2.28 Billion | -2.58 Billion | -728.18 Million | -1.66 Billion | -744.23 Million | -716.41 Million |
| Earnings Per Share Basic | -2.32 | -2.81 | -0.82 | -2.03 | -0.96 | -1.19 |
| Earnings Per Share Diluted | -2.32 | -2.81 | -0.82 | -2.02 | -0.95 | -1.19 |
| Weighted Average Shares Outstanding | 985.3 Million | 917.46 Million | 890.01 Million | 821.97 Million | 778.56 Million | 601.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 985.3 Million | 917.46 Million | 892.65 Million | 824.81 Million | 783.62 Million | 601.91 Million |
| Gross Margin | 0.56 | 0.64 | 0.69 | 0.77 | 0.88 | 0.71 |
| EBIT Margin | -1.44 | -1.64 | -0.11 | -0.96 | -0.91 | -695.16 |
| Profit Margin | -1.52 | -1.78 | -0.18 | -1.04 | -0.96 | -767.04 |
| EBITDA | -2.15 Billion | -2.37 Billion | -422.77 Million | -1.52 Billion | -704.85 Million | -649.28 Million |
| Earnings Before Tax Margin | -1.64 | -1.84 | -0.17 | -1.05 | -0.99 | -727.50 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 405.25 Million | 380.8 Million | 516.09 Million | 1.5 Billion | -669.7 Million | 414.54 Million |
| Cost of Revenue | 102.7 Million | 108.09 Million | 297.54 Million | 667.29 Million | 48.33 Million | 203 Million |
| Gross Profit | 302.54 Million | 272.71 Million | 218.54 Million | 835.26 Million | -718.03 Million | 211.54 Million |
| Operating Expenses | 625.22 Million | 591.28 Million | 1.18 Billion | 3.28 Billion | -17.33 Million | 749.31 Million |
| Selling, General and Administrative Expenses | 488.56 Million | 191.59 Million | 484.21 Million | - | 298.71 Million | 432.47 Million |
| Research and Development Expenses | 270.08 Million | 276.29 Million | 666.84 Million | - | 322.02 Million | 420.93 Million |
| Other Expenses | -5.39 Million | -3.71 Million | - | -35.84 Million | -11.43 Million | -11.47 Million |
| Cost and Expenses | 727.93 Million | 699.37 Million | 1.48 Billion | 3.95 Billion | -305.85 Million | 952.31 Million |
| Operating Income | -322.38 Million | -292.83 Million | -965.64 Million | -2.47 Billion | -291.31 Million | -523.84 Million |
| Interest Expense | 12.7 Million | 11.68 Million | - | 29 Million | - | 6.14 Million |
| Income Tax Expense | 452.4 Thousand | 3.09 Million | 96.38 Million | 43.99 Million | -1.89 Million | -52.66 Million |
| Earnings before Tax | -388.34 Million | -296.54 Million | -884.17 Million | -2.48 Billion | -431.68 Million | -538.37 Million |
| Net Income | -362.66 Million | -283.02 Million | -876.61 Million | -2.28 Billion | -410.39 Million | -452.98 Million |
| Earnings Per Share Basic | -0.37 | -0.29 | -0.89 | - | -0.42 | -0.46 |
| Earnings Per Share Diluted | -0.37 | -0.29 | -0.89 | - | -0.42 | -0.46 |
| Weighted Average Shares Outstanding | 975.96 Million | 975.96 Million | 985.58 Million | 985.3 Million | 976.29 Million | 987.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 975.96 Million | 975.96 Million | 985.58 Million | 985.3 Million | 976.29 Million | 987.01 Million |
| Gross Margin | 0.75 | 0.72 | 0.42 | 0.56 | 1.07 | 0.51 |
| EBIT Margin | -0.80 | -0.83 | -1.74 | - | 0.43 | -1.29 |
| Profit Margin | -0.89 | -0.74 | -1.70 | -1.52 | 0.61 | -1.09 |
| EBITDA | -322.38 Million | -316.44 Million | -900.45 Million | - | -291.31 Million | -533.89 Million |
| Earnings Before Tax Margin | -0.80 | -0.77 | -1.87 | -1.65 | 0.43 | -1.26 |
0520
ATEME
3034
TNRSF
4393
PANACHE